eFlow® Integrated
Our latest nebulizer platform*
built for your clinical success
Driving performance of nebulizer therapy through our
Innovative Breath-Guiding Concept
Flow resistance
for optimized breathing patterns (Fluidic Diode)
via visual and haptic feedback on device and app
No need to choose.
All integrated into one device platform.
INTEGRATION 1
Outstanding Efficiency
High Lung Dose
Combination of excellent delivered dose and high respirable fraction.
Short
Nebulization Time
Critical factor to ensure patient acceptance
Efficiency driven by
membrane for high aerosol output
Adjustable particle size (customization)
Breath-guiding features to support ideal breathing patterns
INTEGRATION 2
Advanced Usability
Ergonomic Design
based on several human factors studies
Smartphone App
Real-time feedback and therapy planning for increased motivation and patient adherence
Considering usability requirements
ergonomic holding position
Secure stand for easy
filling and assembly
Breath-guiding features
for patient comfort and
reassurance
INTEGRATION 3
Innovative & Proven
Benefit from latest PARI technologies while relying on more than 20 years of clinical and commercial experience
Innovative Product Design
based on several human factors studies
Innovative Concept
with real-time breath-guiding
all based on
Established eFlow Technology Platform
Track Record
2010
Altera® for Cayston®
Gilead Sciences Inc. • US, EU, CAN
2015
Zirela® for QUINSAIR™
Horizon • CAN, EU
Tolero® for Vantobra®
PARI Pharma GmbH
2018+
Lamira® for ARIKAYCE®
Insmed Incorporated • EU, JPN, US
Pipeline
8
disclosed projects
20+
undisclosed projects
High Quality Manufacturing
Use of existing, reliable manufacturing and development processes at several PARI sites.
